» Articles » PMID: 32961693

Human Amnion Epithelial Cells Impair T Cell Proliferation: The Role of HLA-G and HLA-E Molecules

Overview
Journal Cells
Publisher MDPI
Date 2020 Sep 23
PMID 32961693
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

The immunoprivilege status characteristic of human amnion epithelial cells (hAECs) has been recently highlighted in the context of xenogenic transplantation. However, the mechanism(s) involved in such regulatory functions have been so far only partially been clarified. Here, we have analyzed the expression of HLA-Ib molecules in isolated hAEC obtained from full term placentae. Moreover, we asked whether these molecules are involved in the immunoregulatory functions of hAEC. Human amnion-derived cells expressed surface HLA-G and HLA-F at high levels, whereas the commonly expressed HLA-E molecule has been measured at a very low level or null on freshly isolated cells. HLA-Ib molecules can be expressed as membrane-bound and soluble forms, and in all hAEC batches analyzed we measured high levels of sHLA-G and sHLA-E when hAEC were maintained in culture, and such a release was time-dependent. Moreover, HLA-G was present in extracellular vesicles (EVs) released by hAEC. hAEC suppressed T cell proliferation in vitro at different hAEC:T cell ratios, as previously reported. Moreover, inhibition of T cell proliferation was partially reverted by pretreating hAEC with anti-HLA-G, anti-HLA-E and anti-β2 microglobulin, thus suggesting that HLA-G and -E molecules are involved in hAEC-mediated suppression of T cell proliferation. Finally, either large-size EV (lsEV) or small-size EV (ssEV) derived from hAEC significantly modulated T-cell proliferation. In conclusion, we have here characterized one of the mechanism(s) underlying immunomodulatory functions of hAEC, related to the expression and release of HLA-Ib molecules.

Citing Articles

Role of Perinatal Stem Cell Secretome as Potential Therapy for Muscular Dystrophies.

Pacilio S, Lombardi S, Costa R, Paris F, Petrocelli G, Marrazzo P Biomedicines. 2025; 13(2).

PMID: 40002871 PMC: 11852414. DOI: 10.3390/biomedicines13020458.


Therapeutic potential of placenta-derived stem cells cultivated on noggin-loaded nanochitosan/polypyrrole-alginate conductive scaffold to restore spinal cord injury.

Manzari-Tavakoli A, Babajani A, Vousooghi N, Moghimi A, Tarasi R, Safaeinejad F Stem Cell Res Ther. 2024; 15(1):497.

PMID: 39716290 PMC: 11668012. DOI: 10.1186/s13287-024-04104-5.


Immunomodulatory properties of extracellular vesicles isolated from bone marrow of patients with neuroblastoma: role of PD-L1 and HLA-G.

Marimpietri D, Corrias M, Tripodi G, Gramignoli R, Airoldi I, Morandi F Front Immunol. 2024; 15:1469771.

PMID: 39512342 PMC: 11540764. DOI: 10.3389/fimmu.2024.1469771.


Characterization of Amnion-Derived Membrane for Clinical Wound Applications.

Ingraldi A, Allen T, Tinghitella J, Merritt W, Becker T, Tabor A Bioengineering (Basel). 2024; 11(10).

PMID: 39451330 PMC: 11504399. DOI: 10.3390/bioengineering11100953.


Current Status and Progress in Stem Cell Therapy for Intracerebral Hemorrhage.

Ding N, Luo R, Zhang Q, Li H, Zhang S, Chen H Transl Stroke Res. 2023; .

PMID: 38001353 DOI: 10.1007/s12975-023-01216-7.


References
1.
Le Bouteiller P, Lenfant F . Antigen-presenting function(s) of the non-classical HLA-E, -F and -G class I molecules: the beginning of a story. Res Immunol. 1996; 147(5):301-13. DOI: 10.1016/0923-2494(96)89643-x. View

2.
Derre L, Corvaisier M, Charreau B, Moreau A, Godefroy E, Moreau-Aubry A . Expression and release of HLA-E by melanoma cells and melanocytes: potential impact on the response of cytotoxic effector cells. J Immunol. 2006; 177(5):3100-7. DOI: 10.4049/jimmunol.177.5.3100. View

3.
Braud V, Allan D, OCallaghan C, Soderstrom K, DAndrea A, Ogg G . HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature. 1998; 391(6669):795-9. DOI: 10.1038/35869. View

4.
Magatti M, De Munari S, Vertua E, Gibelli L, Wengler G, Parolini O . Human amnion mesenchyme harbors cells with allogeneic T-cell suppression and stimulation capabilities. Stem Cells. 2007; 26(1):182-92. DOI: 10.1634/stemcells.2007-0491. View

5.
Strom S, Gramignoli R . Human amnion epithelial cells expressing HLA-G as novel cell-based treatment for liver disease. Hum Immunol. 2016; 77(9):734-9. DOI: 10.1016/j.humimm.2016.07.002. View